Hemispherx BioPharma, Inc (NYSEAMEX:HEB) Investor Files Lawsuit Against Directors
A lawsuit was filed by a current investor in shares of Hemispherx BioPharma, Inc (NYSEAMEX:HEB) over alleged breaches of fiduciary duty by certain directors and NYSEAMEX:HEB stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com
View full press release